Berlin-based, the company commercializes an app to treat digestive diseases and conditions, which spans medication management as well as dietary and mental health interventions to improve gastrointestinal health.
The Company focuses on IBS, IBD, GERD, food intolerances, Crohn’s disease or ulcerative colitis.
Cara Care was acquired by the US company Mahana Therapeutics in February 2024
